Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (6): 668-671.

Previous Articles     Next Articles

Initial study on anticancer effect of serum thymic factor

ZHANG Chang-ping1, LE Jia-jing2, LI Zhan-jun2, XU Kang-sen2   

  1. 1Nanjing Medical University, Nanjing 210029, Jiangsu, China;
    2National Institute for the Control of Pharmaceutical and Biological Products, Beijing 100050, China
  • Received:2007-03-10 Revised:2007-05-16 Published:2020-11-09

Abstract: AIM:To study the inhibitory effect of serum thymic factor (FTS) on cancer cells.METHODS: Bearing cancer mice, rats were administrated with different dosages of FTS. Life extension rate and inhibitory rate were determined. Stimulation index (SI) and delayed hypersensitivity were observed, too.RESULTS:Life extension rate or inhibitory rate in mice exceeded 30% in 0. 25 mg/kg group and 0.13 mg/kg group, and those parameters in rats also exceeded 30% in FTS three groups. After Con-A stimulation, SI achieved maximum at 0. 016 mg/mL.Delayed hypersensitivity also showed positive results.CONCLUSION:FTS has significant inhibitory effect on the growth of EAC, H22 and W256 cancer cells.

Key words: serum thymic factor, inhibitory rate, life extension rate, immunological enhancement

CLC Number: